Rachael Dovey

Rachael Dovey is the Commercial Director at Skin Analytics, a company that is developing advanced AI interventions to assess skin lesions for skin cancer. With over a decade of experience in the UK Healthcare Industry, Rachael is passionate about bringing new products to market to drive change in healthcare. With her deep understanding of the NHS and strong commercial background, Rachael has spent the last five years in HealthTech and has been instrumental in bringing disruptive medTech to market, which includes the first ever deployment of DERM, the only UKCA approved Class IIa AI as a Medical Device for skin cancer in NHS dermatology pathways.